作者：
Hay,A.E. [1]
;
Klimm,B. [2]
;
Chen,B.E. [3]
;
Goergen,H. [4]
;
Shepherd,L.E. [5]
;
Fuchs,M. [6]
;
Gospodarowicz,M.K. [7]
;
Borchmann,P. [8]
;
Connors,J.M. [9]
;
Markova,J. [10]
;
Crump,M. [11]
;
Lohri,A. [12]
;
Winter,J.N. [13]
;
D?rken,B. ;
Pearcey,R.G. ;
Diehl,V. ;
Horning,S.J. ;
Eich,H.T. ;
Engert,A. ;
Meyer,R.M.
作者单位：
NCIC Clinical Trials Group and Queen's University, Kingston, ON, Canada
[1]
Juravinski Hospital and Cancer Centre, Cancer Care Ontario, 711 Concession Street, Hamilton, ON
[2]
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON
[3]
German Hodgkin Study Group, University Hospital of Cologne, Cologne, Germany
[4]
University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague
[5]
Campus Virchow Clinic, Charité-Universit?tsmedizin Berlin, Berlin, Germany
[6]
BC Cancer Agency Centre for Lymphoid Cancer, Vancouver, BC, Canada
[7]
University of Alberta, Edmonton, AB, Canada
[8]
Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, ON
[9]
Medical University Clinic, Liestal, for the Swiss Group for Clinical Cancer Research, Bern
[10]
Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
[11]
Stanford University, Stanford, CA, United States
[12]
Department of Radiation Oncology, University Hospital of Münster, Münster, Germany
[13]
发布时间
2018-06-23
换一批
